Your browser doesn't support javascript.
loading
Drastic Response of Rechallenge of Nivolumab in a Patient with NSCLC Who Progressed on the First Nivolumab Treatment.
Hirano, Satoshi; Hayama, Nami; Tabeta, Hiroshi; Kuroki, Tsuguko; Shiraishi, Yuka; Fujita, Tetsuo; Amano, Hiroyuki; Nakamura, Makoto; Shimizu, Shinichiro; Nakamura, Sukeyuki.
Affiliation
  • Hirano S; Department of Medical Oncology, Funabashi Municipal Medical Center, Chiba, Japan. Electronic address: shirano@mmc.funabashi.chiba.jp.
  • Hayama N; Department of Respiratory Medicine, Funabashi Municipal Medical Center, Chiba, Japan.
  • Tabeta H; Department of Palliative Care Medicine, Funabashi Municipal Medical Center, Chiba, Japan.
  • Kuroki T; Department of Respiratory Medicine, Funabashi Municipal Medical Center, Chiba, Japan.
  • Shiraishi Y; Department of Respiratory Medicine, Funabashi Municipal Medical Center, Chiba, Japan.
  • Fujita T; Department of Respiratory Medicine, Funabashi Municipal Medical Center, Chiba, Japan.
  • Amano H; Department of Respiratory Medicine, Funabashi Municipal Medical Center, Chiba, Japan.
  • Nakamura M; Department of Respiratory Medicine, Funabashi Municipal Medical Center, Chiba, Japan.
  • Shimizu S; Department of Pathology, Funabashi Municipal Medical Center, Chiba, Japan.
  • Nakamura S; Department of Respiratory Medicine, Funabashi Municipal Medical Center, Chiba, Japan.
J Thorac Oncol ; 15(1): e20-e22, 2020 01.
Article in En | MEDLINE | ID: mdl-31864556
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Antineoplastic Agents, Immunological / Lung Neoplasms Limits: Humans Language: En Journal: J Thorac Oncol Year: 2020 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Antineoplastic Agents, Immunological / Lung Neoplasms Limits: Humans Language: En Journal: J Thorac Oncol Year: 2020 Document type: Article